Trials / Completed
CompletedNCT06276647
Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk
Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk: a Pilot Randomized Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this educational clinical trial is to identify high-need women most at risk for poor outcomes following delivery, the problems they experience, and to create a system to improve quality of postpartum care for these high-need patients. The main question\[s\] it aims to answer are: 1. How can the investigators help postpartum patients who have poor outcomes by decreasing the number of ED visits/readmissions for these patients within the first 30 days postpartum? 2. How can the investigators increase the ability of participants to "obtain needed services" and ability for patients to see their provider when they need to, in the 30-day post discharge period as one of the main pathways of unnecessary ED visits? Participants will be put into the study group or control group. The study group will receive a pamphlet postpartum with helpful information as well as a patient navigator who the participants will be able to reach out to their first 30 days postpartum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | HOME | The study intervention consists of a patient education pamphlet and partner sheet (physically and virtually accessible) that will educate and prepare post-partum patients. The patient navigator will explain this pamphlet at postpartum discharge, then will follow-up with the patients up to 30 days in the postpartum period. |
Timeline
- Start date
- 2024-02-20
- Primary completion
- 2025-06-06
- Completion
- 2025-12-05
- First posted
- 2024-02-26
- Last updated
- 2026-04-07
- Results posted
- 2026-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06276647. Inclusion in this directory is not an endorsement.